Belgium-based life sciences company Pronota has finally closed its second round of funding after nearly a year with a final total of €7.9m ($9.8m). Johnson and Johnson Development Corporation, the in-house venture capital arm of the US-based consumer and medical goods company, and MP Healthcare Venture Management, a jointly-owned subsidiary of Mitsubishi Tanabe Pharma Corp and…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
